Comparison of outcomes and prognostic factors for two groups of patients with acute myeloblastic leukemia

Thermochemical scanning probe lithography of protein gradients at the nanoscale.

Nanotechnology·2016

Relationship between neurocognitive functioning and medication management ability over the first 6 months following allogeneic stem cell transplantation.

Bone marrow transplantation·2016

Human albumin eye drops as a therapeutic option for the management of keratoconjunctivitis sicca secondary to chronic graft-versus-host disease after stem-cell allografting.

Current oncology (Toronto, Ont.)·2015

Patient age, remission status and HCT-CI in a combined score are prognostic for patients with AML undergoing allogeneic hematopoietic cell transplantation in CR1 and CR2.

Bone marrow transplantation·2015

Outcomes of patients with therapy-related AML/myelodysplastic syndrome (t-AML/MDS) following hematopoietic cell transplantation.

Bone marrow transplantation·2015

Comparable outcomes post allogeneic hematopoietic cell transplant for patients with de novo or secondary acute myeloid leukemia in first remission.

Bone marrow transplantation·2015

The summa of ZUMA: Lessons from a decade of CD19-targeted CAR-T trials in B-cell malignancies.

Leukemia research·2026

Real-world effectiveness and safety of fixed-duration frontline venetoclax-obinutuzumab for chronic lymphocytic leukemia: A nationwide multicenter retrospective cohort study.

Leukemia research·2026

Real-world outcomes of asciminib versus first- and second-generation tyrosine kinase inhibitors as second-line treatment for chronic-phase chronic myeloid leukemia.

Leukemia research·2026

Bone marrow gene methylation detection for prognostic evaluation in diffuse large B-cell lymphoma.

Leukemia research·2026

Megakaryopoiesis and its dysregulation in paediatric acute megakaryoblastic leukaemia.

Leukemia research·2026

Pediatric-inspired USC-ALL regimen vs hyper-CVAD in adults with Ph-negative and Ph-like acute lymphoblastic leukemia.

Leukemia research·2026

Cardiac adverse event signals of Bruton's tyrosine kinase inhibitors as primary suspect and in co-reported regimens: a large-scale FAERS pharmacovigilance study.

Frontiers in pharmacology·2026

Can we better evaluate responses in higher-risk myelodysplastic syndromes?

Haematologica·2026

Dynamics and clinical significance of coagulation abnormalities following CAR T-cell therapy.

Haematologica·2026

NEDD4 Promotes Hepatocellular Carcinoma Progression Through Ubiquitin-Dependent Degradation of EPHB6.

Cancer science·2026

Patients' preferences for accepting risks and uncertainty in AML treatments within European public health care systems: a cross-sectional study in Finland, Italy, and Germany.

Leukemia & lymphoma·2026

WNT5A-Associated Osteogenic Enhancement Contributes to the Protective Effects of OPG-Fc in Glucocorticoid-Associated Femoral Head Osteonecrosis.

Biomolecules & therapeutics·2026

Comparison of outcomes and prognostic factors for two groups of patients with acute myeloblastic leukemia

Related Experiment Videos

Related Concept Videos

Thermochemical scanning probe lithography of protein gradients at the nanoscale.

Relationship between neurocognitive functioning and medication management ability over the first 6 months following allogeneic stem cell transplantation.

Human albumin eye drops as a therapeutic option for the management of keratoconjunctivitis sicca secondary to chronic graft-versus-host disease after stem-cell allografting.

Patient age, remission status and HCT-CI in a combined score are prognostic for patients with AML undergoing allogeneic hematopoietic cell transplantation in CR1 and CR2.

Outcomes of patients with therapy-related AML/myelodysplastic syndrome (t-AML/MDS) following hematopoietic cell transplantation.

Comparable outcomes post allogeneic hematopoietic cell transplant for patients with de novo or secondary acute myeloid leukemia in first remission.

The summa of ZUMA: Lessons from a decade of CD19-targeted CAR-T trials in B-cell malignancies.

Real-world effectiveness and safety of fixed-duration frontline venetoclax-obinutuzumab for chronic lymphocytic leukemia: A nationwide multicenter retrospective cohort study.

Real-world outcomes of asciminib versus first- and second-generation tyrosine kinase inhibitors as second-line treatment for chronic-phase chronic myeloid leukemia.

Bone marrow gene methylation detection for prognostic evaluation in diffuse large B-cell lymphoma.

Megakaryopoiesis and its dysregulation in paediatric acute megakaryoblastic leukaemia.

Pediatric-inspired USC-ALL regimen vs hyper-CVAD in adults with Ph-negative and Ph-like acute lymphoblastic leukemia.

Cardiac adverse event signals of Bruton's tyrosine kinase inhibitors as primary suspect and in co-reported regimens: a large-scale FAERS pharmacovigilance study.

Can we better evaluate responses in higher-risk myelodysplastic syndromes?

Dynamics and clinical significance of coagulation abnormalities following CAR T-cell therapy.

NEDD4 Promotes Hepatocellular Carcinoma Progression Through Ubiquitin-Dependent Degradation of EPHB6.

Patients' preferences for accepting risks and uncertainty in AML treatments within European public health care systems: a cross-sectional study in Finland, Italy, and Germany.

WNT5A-Associated Osteogenic Enhancement Contributes to the Protective Effects of OPG-Fc in Glucocorticoid-Associated Femoral Head Osteonecrosis.

Comparison of outcomes and prognostic factors for two groups of patients with acute myeloblastic leukemia

Related Experiment Videos

Related Concept Videos

Related Articles